BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25263080)

  • 1. Ten weeks to live: a population-based study on treatment and survival of patients with metastatic pancreatic cancer in the south of the Netherlands.
    Bernards N; Haj Mohammad N; Creemers GJ; de Hingh IH; van Laarhoven HW; Lemmens VE
    Acta Oncol; 2015 Mar; 54(3):403-10. PubMed ID: 25263080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relevance of pathological verification in suspected pancreatic cancer.
    Bernards N; Creemers GJ; Huysentruyt CJ; de Hingh IH; van der Schelling GP; de Bruïne AP; Lemmens VE
    Cancer Epidemiol; 2015 Apr; 39(2):250-5. PubMed ID: 25670054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer.
    van der Geest LGM; Haj Mohammad N; Besselink MGH; Lemmens VEPP; Portielje JEA; van Laarhoven HWM; Wilmink JHW;
    Cancer Med; 2017 Dec; 6(12):2840-2849. PubMed ID: 29035014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy.
    Bernards N; Creemers GJ; Nieuwenhuijzen GA; Bosscha K; Pruijt JF; Lemmens VE
    Ann Oncol; 2013 Dec; 24(12):3056-60. PubMed ID: 24121120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study.
    Thomassen I; Lemmens VE; Nienhuijs SW; Luyer MD; Klaver YL; de Hingh IH
    Pancreas; 2013 Jan; 42(1):72-5. PubMed ID: 22850624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands.
    Haj Mohammad N; Bernards N; Besselink MG; Busch OR; Wilmink JW; Creemers GJ; De Hingh IH; Lemmens VE; van Laarhoven HW
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1353-60. PubMed ID: 26995276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-molecular-weight heparin on survival in patients with advanced pancreatic adenocarcinoma.
    von Delius S; Ayvaz M; Wagenpfeil S; Eckel F; Schmid RM; Lersch C
    Thromb Haemost; 2007 Aug; 98(2):434-9. PubMed ID: 17721628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands.
    Legué LM; Bernards N; Gerritse SL; van Oudheusden TR; de Hingh IH; Creemers GM; Ten Tije AJ; Lemmens VE
    Acta Oncol; 2016; 55(9-10):1183-1189. PubMed ID: 27170100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study.
    Razenberg LG; van Gestel YR; Lemmens VE; de Hingh IH; Creemers GJ
    Clin Colorectal Cancer; 2016 Jun; 15(2):e41-6. PubMed ID: 26762572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.
    Razenberg LG; van Gestel YR; Creemers GJ; Verwaal VJ; Lemmens VE; de Hingh IH
    Eur J Surg Oncol; 2015 Apr; 41(4):466-71. PubMed ID: 25680955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer.
    Haj Mohammad N; Bernards N; van Putten M; Lemmens VEPP; van Oijen MGH; van Laarhoven HWM
    Eur J Cancer; 2017 Jun; 78():28-36. PubMed ID: 28412586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
    Miller RC; Iott MJ; Corsini MM
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in survival for patients with synchronous metastatic esophageal cancer in the south of the Netherlands from 1994 to 2013.
    Bernards N; Haj Mohammad N; Creemers GJ; Rozema T; Roukema JA; Nieuwenhuijzen GA; van Laarhoven HW; van der Sangen M; Lemmens VE
    Acta Oncol; 2016; 55(9-10):1161-1167. PubMed ID: 27174793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004.
    Meulenbeld HJ; van Steenbergen LN; Janssen-Heijnen ML; Lemmens VE; Creemers GJ
    Ann Oncol; 2008 Sep; 19(9):1600-4. PubMed ID: 18467312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival analysis of veteran patients with pancreatic cancer.
    Kim D; Zhu H; Nassri A; Mokdad A; Kukreja S; Polanco P; Huerta S; Ramzan Z
    J Dig Dis; 2016 Jun; 17(6):399-407. PubMed ID: 27235863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis.
    Mackay TM; van Erning FN; van der Geest LGM; de Groot JWB; Haj Mohammad N; Lemmens VE; van Laarhoven HW; Besselink MG; Wilmink JW;
    Eur J Cancer; 2019 Jan; 106():99-105. PubMed ID: 30476732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide improvement of only short-term survival after resection for pancreatic cancer in the Netherlands.
    Nienhuijs SW; van den Akker SA; de Vries E; de Hingh IH; Visser O; Lemmens VE
    Pancreas; 2012 Oct; 41(7):1063-6. PubMed ID: 22617713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008.
    van den Broek CB; Bastiaannet E; Dekker JW; Portielje JE; de Craen AJ; Elferink MA; van de Velde CJ; Liefers GJ; Kapiteijn E
    Acta Oncol; 2013 Jun; 52(5):941-9. PubMed ID: 23145507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very Early Onset Pancreatic Adenocarcinoma - Clinical Presentation, Risk Factors and Therapeutic Options.
    Bunduc Ș; Iacob R; Costache R; Stoica B; Radu C; Gheorghe C
    Chirurgia (Bucur); 2018; 113(3):405-411. PubMed ID: 29981672
    [No Abstract]   [Full Text] [Related]  

  • 20. Pancreatic cancer with malignant ascites: clinical features and outcomes.
    Takahara N; Isayama H; Nakai Y; Sasaki T; Saito K; Hamada T; Mizuno S; Miyabayashi K; Mohri D; Kogure H; Matsubara S; Yamamoto N; Hirano K; Ijichi H; Tateishi K; Tada M; Koike K
    Pancreas; 2015 Apr; 44(3):380-5. PubMed ID: 25636085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.